Budget impact analysis of discontinuing Tyrosin Kinase Inhibitors in patients with chronic myeloid leukemia achieving a complete molecular response by using probabilistic Markov approach (ECOSTIM)

ENCePP Code of conduct

No

ENCePP Seal

This study has been awarded the ENCePP seal

Conflicts of interest of investigators

DOI_Moore2017

Composition of steering group and observers

Observers_ECOSTIM

Signed code of conduct

empty-file.pdf

Signed code of conduct checklist

empty-file.pdf

Signed checklist for study protocols

2017-0043_ENCePP Checklist for Study Protocols_EUPAS18568

Data sources

• Data sources (types):
  Administrative healthcare records (e.g., claims)

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No